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Purpose: This study was performed to investigate the inﬂuence of α-adrenoceptor subtypes upon ureteral smooth
muscle contractile responses. Methods: Rat ureters were challenged in vitro with noradrenaline (NA), the
α1-adrenoceptor agonist phenylephrine (PE), and the α2-adrenoceptor agonist clonidine (CLON). The inﬂuences
of the agonists on the magnitude and frequency of acetylcholine (ACh)-stimulated phasic contractile responses were
recorded. Results: The magnitude of the phasic contractile responses effected by ACh was not signiﬁcantly
inﬂuenced by the adrenoceptor agonists, but the frequency of the response was signiﬁcantly enhanced by all three
agonists (p< 0.05). Idazoxan and prazosin abolished the rise in frequency effected by CLON and PE, respectively,
whereas both antagonists in combination were required to abolish the increase in frequency effected by NA.
Conclusions: It has been demonstrated that α1- and α2-adrenoceptors modulate the contractile function of rat ureteral
smooth muscle by increasing the frequency, but not the magnitude, of phasic contractile responses. The enhancement
of contractile function by NA is mediated by mechanisms dependent upon both α1- and α2-adrenoceptors.
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Introduction
Peristaltic activity of ureteral smooth muscle propels urine from the kidneys to the urinary
bladder. The muscular layer within the wall of the ureter comprises both circular and
longitudinal layers of smooth muscle and the peristaltic function arises from a pacemaker
system within the renal pelvis, as reviewed by Lang and Klemm (13) and Hammad (3).
However, autonomic inﬂuences can modulate the contractile function, and the existence of
cholinergic (2, 19, 20) and adrenergic (2, 20) nerve ﬁbers within the ureteral wall has been
demonstrated; the ﬁbers from those two branches of the autonomic nervous system run in
close association indicating potential for functional interaction (2, 20). Regarding adreno-
ceptor modulation of ureteral smooth muscle function, β-adrenoceptors have been identiﬁed
within the muscle, which have an attenuating inﬂuence upon ureteral contractile function
(6, 25). In addition, α-adrenoceptors have been identiﬁed within the ureters of several species,
which enhance ureteral contractile function (6, 11, 12, 22).
Regarding rodent preparations, it has been demonstrated that rat ureteral phasic motility
is diminished by α1A-adrenoceptor antagonism (12). Further evidence in support of a
contribution of α1A-adrenoceptors to rat ureteral smooth muscle tone is the expression of
α1A-adrenoceptors mRNA in ureteral tissue, with signiﬁcantly lower levels of α1B- and
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α1D-adrenoceptors mRNA with concomitant smaller inhibitory effects exerted by α1B- and
α1D-adrenoceptors antagonism in comparison with those of α1A-adrenoceptor antagonism
(10). There have been few reports in relation to adrenergic control of rat ureteral contractile
function. Tindall (22) and Hannapel and Golenhofen (4) described modulation of rat ureteral
motility by α- and β-adrenoceptors, and Tomiyama et al. (23) reported that the β1-adrenoceptor
subtype is predominately responsible for β-adrenoceptor-mediated relaxation. Also of
relevance to this study are the ﬁndings of Harada et al. (5); intravenous administration of
an α2-adrenoceptor agonist increased ureteral contractile frequency and in addition the ureteral
baseline pressure and contractile responses. The study by Harada et al. (5) also demonstrated
that α2-adrenoceptor antagonism reduces baseline ureteral pressures and contractile frequency.
Villa et al. (24) have also reported that intravenous administration of α1-adrenoceptor
antagonists reduces ureteral pressure, although there was no signiﬁcant inﬂuence on the
amplitude and frequency of contraction. Of interest is the observation that contractile
responses evoked by electrical ﬁeld stimulation in vitro were reduced by α1-adrenoceptor
antagonism (24). In the clinical setting, treatment with α1-adrenoceptor antagonists is used to
promote the passage of stones through ureters by means of ureteral smooth muscle relaxation
(18). To date, no study, to the best of our knowledge, has investigated the contribution of both
α1- and α2-adrenoceptors in the determination of rat ureteral motility. Therefore, the purpose of
this study was to examine the inﬂuence of noradrenaline (NA) upon rat ureteral smooth muscle
function in vitro and to determine, for the ﬁrst time, contributions of both α1- and α2-
adrenoceptors to the excitatory function of NA in the rat ureter.
Materials and Methods
All procedures were performed in accordance with the guidelines in force at University
College Dublin. Male Wistar rats (body weights: 250–350 g) were used in this study and were
maintained on standard rat chow and tap water ad libitum. Rats were killed by a stunning
blow to the head followed rapidly by cervical dislocation. Ureters were dissected free and
transported to the laboratory in ice–cold physiological saline solution (PSS) of the following
composition (mM): 119 NaCl, 4.7 KCl, 25 NaHCO3, 1.18 KH2PO4, 1.17 MgSO4, 0.026 K2-
EDTA, 5.5 D(+)-glucose, and 1.6 CaCl2. In order to identify the proximal end of each ureter,
some renal tissue was left attached when they were removed.
Ureters were cleared of extraneous tissue under a binocular microscope and 15-mm
segments from the proximal region were suspended in 20 ml capacity water-jacketed tissue
baths containing PSS: one end was secured to a tissue holder in the bath by means of cotton
thread, whereas the other was secured to a force transducer in a similar fashion. The baths
were then warmed to 37 °C and gassed with 5% CO2 in air. A pretension of 0.2 g was applied
and ureteral segments were allowed to equilibrate under these conditions for 40 min before
the addition of any reagents. Acetylcholine (ACh; muscarinic agonist), NA (non-speciﬁc
adrenoceptor agonist), phenylephrine (PE; α1-adrenoceptor agonist), and clonidine (CLON;
α2-adrenoceptor agonist) were dissolved in deionized water (10−2 M) and stored as frozen
1 ml aliquots. Idazoxan (IDAZ; α2-adrenoceptor antagonist) was similarly prepared at a
concentration of (10−3 M). Prazosin (PRZ; α1-adrenoceptor antagonist) was dissolved in
0.1% dimethyl sulfoxide and stored as 100 μl aliquots in the freezer. Pilot experiments
demonstrated that NA and PE were without effect on quiescent ureters but were able to
modulate the contractile responses effected by ACh.
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Protocol 1: Inﬂuence of NA and PE on ureteral motility
Ureters were challenged with ACh (10−5 M) and consistently generated phasic contractile
responses, as reported previously (e.g., 9, 16). After 5 min to allow stabilization of the
response, an adrenoceptor agonist was added for another 5 min and the tissue was washed
with fresh PSS. After 40 min, the protocol was repeated with the other adrenoceptor agonist;
NA (10−5 M) and PE (10−5 M) were applied in different orders for different ureter segments.
The contractile responses in the ﬁnal 3 min of each adrenoceptor agonist application were
used for calculation of contractile frequency (min−1); the magnitude of contractile responses
was taken as the average of the ﬁnal two contractile responses during each treatment regime.
Protocol 2: Inﬂuence of PRZ on ureteral motility
Protocol 2 was identical to Protocol 1 with the exception that PRZ (10−5 M) was present
during the applications of NA and PE.
Protocol 3: Inﬂuence of CLON on ureteral motility
This protocol was conducted in an identical manner to Protocol 1 with the exception that
CLON (10−5 M) was applied twice, with IDAZ (10−6 M) present during the second
challenge.
Protocol 4: Inﬂuence of IDAZ and PRZ on the NA-mediated effects on ureteral motility
This protocol was conducted in an identical manner to Protocol 1 with the exception that NA
(10−5 M) was applied twice with IDAZ (10−6 M) present during the ﬁrst challenge and both
IDAZ (10−6 M) and PRZ (10−5 M) present during the second challenge.
Statistical analysis
Data are presented as mean± SEM. A two-tailed paired Student’s t-test was used to compare
contractile responses before and after the addition of NA, PE, or CLON.
Results
Contractile frequency
The ureteral smooth muscle contractile frequency initiated by ACh was signiﬁcantly
increased by NA, PE, and CLON (Fig. 1). PE failed to effect an increase in the frequency
of contractions in the presence of PRZ (2.24± 0.45 and 2.00± 0.38 g before and after the
addition of PE, respectively, n= 7, NS). CLON failed to effect an increase in the frequency of
contractions in the presence of IDAZ (3.67± 0.42 and 4.22± 0.63 g before and after the
addition of CLON, respectively, n= 6, NS). The stimulatory effect of NA was still apparent
in the presence of PRZ or IDAZ alone but not in the combined presence of both PRZ and
IDAZ (Fig. 2).
Magnitude of contractile responses
Contractile force was not signiﬁcantly inﬂuenced by NA, PE, or CLON (Table I).
Discussion
Catecholamines modulate ureteral contractile responses through their interactions with a
number of adrenoceptor subtypes with excitatory and inhibitory effects resulting from
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α- and β-adrenoceptor activation, respectively. Although rat ureters are readily available
tissues for investigation, there are few published reports concerning the modulation of
ureteral contractile function in this species and accordingly this study was designed to
investigate the nature of the modulation effected by α1- and α2-adrenoceptors through the
use of speciﬁc and non-speciﬁc agonists and antagonists. We now report that NA increases
the frequency of contractile responses with no concomitant effect upon the magnitude of
contractile behavior of rat ureteral smooth muscle. Furthermore, we ﬁrst report that this
positive chronotropic effect is mediated by the activation of both α1- and α2-adrenoceptor
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Fig. 1. The inﬂuence of noradrenaline (NA;
panel A), phenylephrine (PE; panel B), and
clonidine (CLON; panel C) on the frequency
(min−1) of acetylcholine (ACh)-stimulated
contractile responses of rat ureter segments.
Data presented as mean± SEM. *p< 0.05.
Student’s two-tailed paired t-test
228 Monks and Bund
Physiology International (Acta Physiologica Hungarica) 105, 2018
subtypes in the rat, consistent with observations made in in vivo studies (5, 24), which
separately identiﬁed roles for those adrenoceptor subtypes.
In the rat, an outer longitudinal layer of smooth muscle has been shown to surround
an inner circular layer (1, 7) and working in conjunction, the activities of the layers
generate peristaltic waves that raise intraureteral pressure. There is evidence for different
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Fig. 2. The inﬂuence of noradrenaline (NA) on
the frequency (min−1) of acetylcholine (ACh)-
stimulated contractile responses of rat ureter
segments in prazosin (PRZ; panel A), idazoxan
(IDAZ; panel B), and the combination of both
PRZ and IDAZ (panel C). Data presented as
mean± SEM. **p< 0.01. Student’s two-tailed
paired t-test
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responsiveness in sheep ureter preparations depending upon the orientation of the prepara-
tions (17); therefore, muscle layers in different orientations may be subjected to differential
control. The preparation utilized in this study will mainly record the activity of longitudinally
arranged smooth muscle. However, recent work has suggested that the muscular component
of the rat ureter comprises a predominantly longitudinal layer with no separate circular layer;
toward the lamina propria the smooth muscles are arranged in a dispersed fashion but
maintaining a mainly longitudinal orientation (21). Given this recent ultrastructural evidence,
it is considered most likely that the observations presented in this study are not limited by the
possibility of an underestimation of the contribution of circularly arranged smooth muscle to
ureteral function. Nevertheless, our experiments do not provide information regarding
pressure generation within the ureter. It should also be noted that regional heterogeneity
exists in relation to the motility of ureters. For example, proximal and distal regions of the
ureter exhibit different relative contributions to motility afforded by α- and β-adrenoceptors
(4, 22). In this study, only segments from the proximal region of the ureter were used to avoid
this potentially confounding property.
This study demonstrates that NA exerts a positive chronotropic inﬂuence mediated by
both α1- and α2-adrenoceptor subtypes; combined antagonism of α1- and α2-adrenoceptors is
required to fully inhibit this effect, whereas antagonism of α1- and α2-adrenoceptors
separately mediates partial inhibition. Both PE and CLON effected increased contractile
frequency and those effects were inhibited by PRZ and IDAZ, respectively, providing
functional evidence for α1- and α2-adrenoceptors. As described above, NA when applied
alone does not stimulate contractile responses in the rat ureter in our laboratory. However,
given that this adrenergic agent can modify the response effected by ACh, this provides
support for the hypothesis that adrenergic and cholinergic nerves may functionally interact as
hypothesized previously (2, 20).
It was of particular interest to note that NA and, in addition, PE and CLON exerted a
positive chronotropic inﬂuence but no inotropic inﬂuence. This raises the question of where
the functionally expressed adrenoceptors are located. In this regard, the pacemaker activity of
interstitial cells of Cajal (ICC) or ICC-like cells within smooth muscle is reported to be
subjected to modulation by adrenoceptors (8, 26, 27) and it could be hypothesized that they
are expressed on the cells responsible for the rhythmic pacemaker activity observed in
contracting rat ureters rather than the smooth muscle cells. A similar suggestion has been
provided by Lee et al. (14) who demonstrated the existence of ICC in the proximal, but not
distal, regions of the human ureter.
Table I. Inﬂuence of adrenoceptor agonists on the magnitude of acetylcholine-stimulated contractile response
Contractile response (g)
Agonist Before addition After addition
NA (n= 6) 0.06± 0.01 0.04± 0.01
PE (n= 7) 0.07± 0.01 0.08± 0.01
CLON (n= 6) 0.11± 0.02 0.15± 0.02
Data presented as mean± SEM. Noradrenaline (NA), phenylephrine (PE), and clonidine (CLON) did not signiﬁ-
cantly inﬂuence the magnitude (g) of acetylcholine-stimulated contractile responses of rat ureter segments
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It has been reported that ICC are not present in the ureter, although they are present in
the pelvicalyceal junction; they are not considered to be the primary pacemaker cells with that
function ascribed to ICC-like or atypical smooth muscle cells (13, 15). However, it remains a
possibility that there are pacemaker cells within the wall of the ureter whose adrenoceptor
function is responsible for the increased contraction frequency observed in this study when
the ureter segments were challenged with NA.
In summary, this study has demonstrated that NA stimulates an increased frequency of
contraction in the rat ureter through activation of α1- and α2-adrenoceptors. We put forward the
hypothesis that this effect is mediated through pacemaker cell function. Further understanding
of the mechanisms of control of ureteral function may advance our understanding of conditions
of clinical relevance, such as vesicoureteral reﬂux or ureter stone passage.
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